These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12608887)

  • 61. Efficacy of the oral neurokinin-1 receptor antagonist aprepitant for nausea and vomiting induced by cisplatin and carboplatin in Japanese patients with gynecological cancer.
    Ikeda M; Shida M; Hirasawa T; Muramatsu T; Mikami M
    J Obstet Gynaecol Res; 2017 Oct; 43(10):1613-1620. PubMed ID: 28691209
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Review article: the evolution of endpoint assessments for chemotherapy-induced nausea and vomiting and post-operative nausea and vomiting-a perspective from the US Food and Drug Administration.
    Gabby ME; Bugin K; Lyons E
    Aliment Pharmacol Ther; 2021 Jul; 54(1):7-13. PubMed ID: 33982324
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recent advances in the understanding and management of postoperative nausea and vomiting.
    Gin T
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):114-9. PubMed ID: 7710220
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomiting.
    Janicki PK; Sugino S
    Exp Brain Res; 2014 Aug; 232(8):2613-25. PubMed ID: 24792505
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of three dose levels of ICS 205-930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomiting.
    Seinen H; Zonnenberg BA; Tjia P; Neijt JP
    Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1333-5. PubMed ID: 2806357
    [No Abstract]   [Full Text] [Related]  

  • 67. Efficacy of amisulpride on postoperative nausea and vomiting: a systematic review and meta-analysis.
    Zhang LF; Zhang CF; Tang WX; He L; Liu Y; Tian DD; Ai YQ
    Eur J Clin Pharmacol; 2020 Jul; 76(7):903-912. PubMed ID: 32274525
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Therapeutic management of nausea and vomiting.
    Marin J; Ibañez MC; Arribas S
    Gen Pharmacol; 1990; 21(1):1-10. PubMed ID: 2404830
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Amisulpride: A Review in Post-Operative Nausea and Vomiting.
    Kang C; Shirley M
    Drugs; 2021 Feb; 81(3):367-375. PubMed ID: 33656662
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence.
    Mersiades AJ; Stockler MR; Olver IN; Grimison P
    Med J Aust; 2019 Jan; 210(1):11-12.e1. PubMed ID: 30636299
    [No Abstract]   [Full Text] [Related]  

  • 71. Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy.
    Roberts SM; Bezinover DS; Janicki PK
    Cancer Manag Res; 2012; 4():67-73. PubMed ID: 22427733
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The efficacy of 5HT3-receptor antagonists in postoperative nausea and vomiting: the role of pharmacogenetics.
    Theodosopoulou P; Rekatsina M; Staikou C
    Minerva Anestesiol; 2023 Jun; 89(6):565-576. PubMed ID: 36852569
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serotonin antagonists. An update.
    Harvey RD; Lindley CL
    Cancer Pract; 1998; 6(2):133-5. PubMed ID: 9573914
    [No Abstract]   [Full Text] [Related]  

  • 74. Ondansetron induced fatal ventricular tachycardia.
    Chandrakala R; Vijayashankara CN; Kumar KK; Sarala N
    Indian J Pharmacol; 2008 Aug; 40(4):186-7. PubMed ID: 20040955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiovascular and Adverse Effects of Glucagon for the Management of Suspected Beta Blocker Toxicity: a Case Series.
    Senart AM; LeClair LA
    J Med Toxicol; 2023 Jan; 19(1):9-15. PubMed ID: 36479689
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chemotherapy-induced nausea and vomiting incidence and prevalence.
    Grunberg SM
    Am Soc Clin Oncol Educ Book; 2012; ():541-3. PubMed ID: 24451792
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Postoperative nausea and vomiting: prevention and therapy.
    Harter RL
    Curr Opin Anaesthesiol; 2000 Aug; 13(4):469-73. PubMed ID: 17016343
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of amosyt tablets on postoperative vomiting].
    RUBEN H
    Ugeskr Laeger; 1951 Apr; 113(16):491-2. PubMed ID: 14846230
    [No Abstract]   [Full Text] [Related]  

  • 79. Health risks from indoor gas appliances.
    Ewald B; Crisp G; Carey M
    Aust J Gen Pract; 2022 Dec; 51(12):935-938. PubMed ID: 36451320
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.